Get started
Author

Sara Duhachek-Muggy

Observed names: Duhachek Muggy, Sara, Duhachek-Muggy, Sara, S Duhachek-Muggy, Sara Duhacheck-Muggy, Sara Duhachek Muggy
OpenAlex ID: A5086854401
Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer
2018 · Le Zhang, Milana Bochkur Dratver, et al. · International Journal of Radiation Oncology*Biology*Physics · 73
The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma
2020 · Kruttika Bhat, Mohammad Saki, et al. · Proceedings of the National Academy of Sciences · 65
PDF
Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
2017 · Sara Duhachek-Muggy, Yue Qi, et al. · Molecular Cancer · 64
PDF
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
2015 · Sara Duhachek-Muggy, Anna Zolkiewska · BMC Cancer · 44
PDF
Metalloprotease-Disintegrin ADAM12 Expression Is Regulated by Notch Signaling via MicroRNA-29
2011 · Hui Li, Emilia Solomon, et al. · Journal of Biological Chemistry · 41
PDF
Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells
2016 · Randi Wise, Sara Duhachek-Muggy, et al. · Breast Cancer Research and Treatment · 38
An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer
2012 · Hui Li, Sara Duhachek-Muggy, et al. · Breast Cancer Research and Treatment · 36
The Role of SnoN in Transforming Growth Factor β1-induced Expression of Metalloprotease-Disintegrin ADAM12
2010 · Emilia Solomon, Hui Li, et al. · Journal of Biological Chemistry · 34
PDF
Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype
2013 · Hui Li, Sara Duhachek-Muggy, et al. · Breast Cancer Research and Treatment · 27
PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation
2019 · Le Zhang, Justine Bailleul, et al. · Breast Cancer Research and Treatment · 26
Radiation mitigation of the intestinal acute radiation injury in mice by 1-[(4-nitrophenyl)sulfonyl]-4-phenylpiperazine
2019 · Sara Duhachek-Muggy, Kruttika Bhat, et al. · Stem Cells Translational Medicine · 18
PDF
Serum erythropoietin levels, breast cancer and breast cancer-initiating cells
2019 · Kruttika Bhat, Kiri Sandler, et al. · Breast Cancer Research · 15
PDF
Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer
2020 · Ling He, Kruttika Bhat, et al. · Neoplasia · 12
PDF
Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12
2014 · Yue Qi, Sara Duhachek-Muggy, et al. · PLoS ONE · 12
PDF
1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine increases the number of Peyer’s patch-associated regenerating crypts in the small intestines after radiation injury
2018 · Kruttika Bhat, Sara Duhachek-Muggy, et al. · Radiotherapy and Oncology · 11
Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants
2013 · Sara Duhachek-Muggy, Hui Li, et al. · PLoS ONE · 11
PDF
Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal Irradiation
2017 · Sara Duhachek-Muggy, Kruttika Bhat, et al. · Radiation Research
Additional file 9: Figure S8. of Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
2017 · Duhachek-Muggy, Sara, Qi, Yue, et al. · Figshare
Additional file 3: Figure S2. of Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
2017 · Duhachek-Muggy, Sara, Qi, Yue, et al. · Figshare
Additional file 1: Table S1. of Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
2017 · Duhachek-Muggy, Sara, Qi, Yue, et al. · Figshare
Abstract B43: ADAM12 is a novel regulator of stem-like cells in triple-negative breast cancer
2016 · Yue Qi, Sara Duhachek-Muggy, et al. · Cancer Research
Abstract A40: Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells
2016 · Randi Wise, Sara Duhachek-Muggy, et al. · Cancer Research
Abstract P2-08-05: Functional characterization of three novel breast cancer-related somatic mutations in metalloproteinase-disintegrin ADAM12
2013 · Y Qi, S Duhachek-Muggy, et al. · Cancer Research
Abstract B133: Metalloprotease-disintegrin ADAM12-L in breast cancer cells: Regulation of expression by microRNA-200b/c
2013 · Sara Duhachek-Muggy, Anna Zolkiewska · Molecular Cancer Research
Works count: 35
Citation count: 527
H-index: 12
I10-index: 16
Year
Topic
Type